Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Regis
about
Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in ChinaED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDRBleeding risk stratification in an era of aggressive management of acute coronary syndromesOutcome of the HORIZONS-AMI trial: bivalirudin enhances long-term survival in patients with ST-elevation myocardial infarction undergoing angioplasty.Hospital variability in use of anticoagulant strategies during acute myocardial infarction treated with an early invasive strategy.Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysisMeasures of risk and their relationship to the relative size of a high-risk group: application to medical thromboprophylaxis.Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin.Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome.Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segmenCurrent state of medical thromboprophylaxis in Australia.How serious a problem is bleeding in patients with acute coronary syndromes?Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.Lessons learned from negative clinical trials evaluating antithrombotic therapy for ischemic heart disease.Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study.Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of EEstimation of clinical and economic effects of prophylaxis against venous thromboembolism in medical patients, including the effect of targeting patients at high-risk.Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome.Bivalirudin use and one-month outcome in the context of contemporary antiplatelet treatment: insights from the Greek Antiplatelet Registry.ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome
P2860
Q33615438-DE845EAD-E3DD-4365-9D69-CEAE24775772Q33710731-8995FA3E-DAB5-479C-8062-7D7B2C59CD72Q34574018-29BFA58F-71FA-4056-8BC9-9EBD6A14E664Q35808743-BBE6A411-2F43-4FFF-B4C0-0E3EAB9DDDD7Q36142016-5D1D4CBE-4B6C-46E0-B320-6255AF3AC81CQ36151537-DFD28119-BDDB-4E55-BF0E-FCAC7A10D07DQ36393768-AD70D49C-5D12-49E2-A324-BA413A5B5116Q36706368-9CCEF91D-3E5A-4C44-BD4E-C1C88080854EQ37140945-5A37BB47-C6DC-47BE-A537-FF107B547379Q37240704-00A8C9B9-E16A-4D2D-ACFC-E23139648932Q37291851-6CDA8C68-5E70-4668-B6B3-AA272B7F3176Q37426083-9FD81990-866C-4AFE-9B7A-CDBBBEA5AC88Q37615784-A76AF898-E418-4C19-BEB7-1403BBF2A146Q37888541-008BB57C-84EC-4E28-A761-95378C113930Q38095795-668AB4A6-4D2A-4EFF-A1B8-418F602A5C78Q38182003-C58630E2-FFB7-43C0-8F93-C39340B3DAFDQ38388751-6B6748AB-E51F-471A-BCC9-A855CB7754ADQ38656364-50972E68-D419-451B-9474-051588E8192CQ40125430-A5601F85-B8E4-454F-B1B3-F9607F45B6C8Q41643200-5A2E7042-2AA8-492F-8B34-DFE47D96A6C4Q44013094-23448842-E204-4DC2-A226-C49E754E2D06Q57764209-F5E26B88-B209-4FEF-BB82-4793ED799E8A
P2860
Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Regis
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@ast
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@en
type
label
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@ast
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@en
prefLabel
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@ast
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@en
P2093
P1476
Use of anticoagulant agents an ...... vention Outcomes Network Regis
@en
P2093
Anita Y Chen
Benjamin M Scirica
Christopher P Cannon
Joanne M Foody
Karen P Alexander
Mitul B Kadakia
Nihar R Desai
Stephen D Wiviott
P304
P356
10.1016/J.JCIN.2010.08.015
P577
2010-11-01T00:00:00Z